Surface-modified microprojection arrays for intradermal biomarker capture, with low non-specific protein binding
Simon R Corrie1, Germain J P Fernando, Michael L Crichton
1The University of Queensland, Australian Institute for Bioengineering and Nanotechnology, St Lucia, QLD 4072, Australia. s.corrie1@uq.edu.au
Lab on a Chip
|September 8, 2010
Summary
This study presents a novel minimally invasive biosensor for rapid point-of-care diagnostic screening. The device extracts disease biomarkers from the upper dermis, avoiding needles and complex blood processing for faster results.
Area of Science:
- Biomedical Engineering
- Biosensor Technology
- Diagnostic Devices
Background:
- Minimally invasive biosensors are crucial for rapid point-of-care diagnostic screening.
- Current methods often rely on invasive procedures like needle-based blood draws and resource-intensive processing.
- There is a need for simpler, less invasive methods to detect disease biomarkers.
Purpose of the Study:
- To introduce and validate a novel device for extracting disease-specific biomarkers directly from the upper dermis.
- To demonstrate the analytical specificity and sensitivity of this new extraction method.
- To compare the performance of the new device against conventional blood-based diagnostic techniques.
Main Methods:
- Development of a minimally invasive device for biomarker extraction from the upper dermis.
- Utilizing antigen-specific antibodies (raised in mice) for biomarker capture and extraction.
- Analytical validation of specificity and sensitivity using a mouse model.
- Comparison with conventional methods involving needle/syringe blood collection and ELISA.
Main Results:
- The novel device successfully extracts disease-specific biomarkers from the upper dermis.
- Analytical specificity and sensitivity were confirmed using antibody capture and extraction.
- Performance was comparable to traditional methods, but with a minimally invasive approach.
Conclusions:
- The developed device offers a promising minimally invasive alternative for point-of-care diagnostic screening.
- This technology eliminates the need for needles and complex blood processing, enabling faster biomarker detection.
- Further research can explore broader applications for various disease biomarkers.


